BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
$3.620-0.230 (-5.974%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.850
High
$3.860
Low
$3.620
Volume
0.96M
Company Fundamentals
Market Cap
206.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.92M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.195Current $3.620High $4.45
Related News
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $10
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and lowers the price target from $12 to $10.
View more
GlobeNewswire
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership opportunities to advance
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.